The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Does antipsychotic polypharmacy increase the risk for metabolic syndrome?
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Toprak, O., Kurt, H., Sarı, Y., Şarkış, C., Us, H., & Kırık, A. (2017) · Kidney and Blood Pressure Research · doi:10.1159/000468530 · Cited by 29,627
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,947
Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011
Antipsychotic-induced weight gain: a comprehensive research synthesis
Allison, D. B., Mentore, J. L., Heo, M., Chandler, L. P., Cappelleri, J. C., Infante, M. C., & Weiden, P. J. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.11.1686 · Cited by 2,382
Medical Consequences of Obesity
Bray, G. A. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0535 · Cited by 1,538
Discovering the Neural Basis of Human Social Anxiety: A Diagnostic and Therapeutic Imperative
Charney, D. S. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.1.1 · Cited by 1,428
Obesity, Metabolic Syndrome, and Cardiovascular Disease
Grundy, S. M. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0372 · Cited by 1,371
Second-Generation (Atypical) Antipsychotics and Metabolic Effects: A Comprehensive Literature Review
Newcomer, J. W. (2005) · CNS Drugs · doi:10.2165/00023210-200519001-00001 · Cited by 1,340
Consensus Development Conference on Antipsychotic Drugs and Obesity and Diabetes
Boehm, G., Racoosin, J. A., Laughren, T. P., & Katz, R. (2004) · Diabetes Care · doi:10.2337/diacare.27.8.2088-a · Cited by 1,204
McEvoy, J. P., Meyer, J. M., Goff, D. C., Nasrallah, H. A., Davis, S. M., Sullivan, L., Meltzer, H. Y., Hsiao, J., Scott Stroup, T., & Lieberman, J. A. (2005) · Schizophrenia Research · doi:10.1016/j.schres.2005.07.014 · Cited by 1,140
Causes of the excess mortality of schizophrenia
Brown, S., Inskip, H., & Barraclough, B. (2000) · British Journal of Psychiatry · doi:10.1192/bjp.177.3.212 · Cited by 1,087
Practice Guideline for the Treatment of Patients With Schizophrenia Second Edition
(2007) · APA Practice Guidelines for the Treatment of Psychiatric Disorders: Comprehensive Guidelines and Guideline Watches · doi:10.1176/appi.books.9780890423363.45859 · Cited by 737
Mortality and causes of death in schizophrenia in Stockholm County, Sweden
Ösby, U., Correia, N., Brandt, L., Ekbom, A., & Sparén, P. (2000) · Schizophrenia Research · doi:10.1016/s0920-9964(99)00191-7 · Cited by 679 · cited 1×
“However, in light of findings that patients with schizophrenia are also at particular risk for cardiovascular morbidity and mortality (55,56), the combined impact of more than one antipsychotic creates concern in clinical practice.”
BackgroundMcLaughlin, T., Reaven, G., Abbasi, F., Lamendola, C., Saad, M., Waters, D., Simon, J., & Krauss, R. M. (2005) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2005.03.085 · Cited by 658
Goff, D. C., Sullivan, L. M., McEvoy, J. P., Meyer, J. M., Nasrallah, H. A., Daumit, G. L., Lamberti, S., D'Agostino, R. B., Stroup, T. S., Davis, S., et al. (2005) · Schizophrenia Research · doi:10.1016/j.schres.2005.08.010 · Cited by 528
Marder, S. R., McQuade, R. D., Stock, E., Kaplita, S., Marcus, R., Safferman, A. Z., Saha, A., Ali, M., & Iwamoto, T. (2003) · Schizophrenia Research · doi:10.1016/s0920-9964(03)00050-1 · Cited by 467
Schizophrenia, neuroleptic medication and mortality
Joukamaa, M., Heliövaara, M., Knekt, P., Aromaa, A., Raitasalo, R., & Lehtinen, V. (2006) · British Journal of Psychiatry · doi:10.1192/bjp.188.2.122 · Cited by 395
(2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n0219 · Cited by 383
Suppes, T., Dennehy, E. B., Hirschfeld, R. M. A., Altshuler, L. L., Bowden, C. L., Calabrese, J. R., Crismon, M. L., Ketter, T. A., Sachs, G. S., Swann, A. C., et al. (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n0710 · Cited by 330
The Effects of Novel Antipsychotics on Glucose and Lipid Levels
Wirshing, D. A., Jennifer A., J. A., Meng, L. R., Ballon, J. S., Marder, S. R., & Wirshing, W. C. (2002) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v63n1002 · Cited by 294
Clozapine alone versus clozapine and risperidone with refractory schizophrenia
Honer, W. G., Thornton, A. E., Chen, E. Y. H., Chan, R. C. K., Wong, J. O. Y., Bergmann, A., Falkai, P., Pomarol-Clotet, E., McKenna, P. J., Stip, E., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa053222 · Cited by 277
Waddington, J. L., Youssef, H. A., & Kinsella, A. (1998) · British Journal of Psychiatry · doi:10.1192/bjp.173.4.325 · Cited by 267
Shiloh, R., Zemishlany, Z., Aizenberg, D., Radwan, M., Schwartz, B., Dorfman-Etrog, P., Modai, I., Khaikin, M., & Weizman, A. (1997) · British Journal of Psychiatry · doi:10.1192/bjp.171.6.569 · Cited by 260
Cohn, T., Prud'homme, D., Streiner, D., Kameh, H., & Remington, G. (2004) · The Canadian Journal of Psychiatry · doi:10.1177/070674370404901106 · Cited by 254
Auquier, P., Lançon, C., Rouillon, F., Lader, M., & Holmes, C. (2006) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1325 · Cited by 249
McQuade, R. D., Stock, E. G., Marcus, R. N., Jody, D. N., Abou-Gharbia, N., Vanveggel, S., Archibald, D., & Carson, W. H. (2004) · PubMed · Cited by 244
The Texas Medication Algorithm Project Antipsychotic Algorithm for Schizophrenia: 2003 Update
Miller, A. L., Hall, C. S., Buchanan, R. W., Buckley, P. F., Chiles, J. A., Conley, R. R., Crismon, M. L., Ereshefsky, L., Essock, S. M., Finnerty, M., et al. (2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n0408 · Cited by 234
Josiassen, R. C., Joseph, A., Kohegyi, E., Stokes, S., Dadvand, M., Paing, W. W., & Shaughnessy, R. A. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.1.130 · Cited by 233
Sumner, A. E., Finley, K. B., Genovese, D. J., Criqui, M. H., & Boston, R. C. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.12.1395 · Cited by 230
Ganguly, R., Kotzan, J. A., Miller, L. S., Kennedy, K., & Martin, B. C. (2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n1013 · Cited by 227
Correll, C. U., Frederickson, A. M., Kane, J. M., & Manu, P. (2006) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v67n0408 · Cited by 216
Self-citationClark, R. E., Bartels, S. J., Mellman, T. A., & Peacock, W. J. (2002) · Schizophrenia Bulletin · doi:10.1093/oxfordjournals.schbul.a006928 · Cited by 189
Yagcioglu, A. E. A., Akdede, B. B. K., Turgut, T. I., Tümüklü, M., Yazici, M. K., Alptekin, K., Ertugrul, A., Jayathilake, K., Gögüs, A., Tunca, Z., et al. (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n0109 · Cited by 185
Faries, D., Ascher-Svanum, H., Zhu, B., Correll, C., & Kane, J. (2005) · BMC Psychiatry · doi:10.1186/1471-244x-5-26 · Cited by 184
Self-citationCombination Antipsychotic Therapy in Clinical Practice
Tapp, A., Wood, A. E., Secrest, L., Erdmann, J., Cubberley, L., & Kilzieh, N. (2003) · Psychiatric Services · doi:10.1176/appi.ps.54.1.55 · Cited by 181
Simpson, G. M., Glick, I. D., Weiden, P. J., Romano, S. J., & Siu, C. O. (2004) · American Journal of Psychiatry · doi:10.1176/ajp.161.10.1837 · Cited by 170
Sim, K., Su, A., Fujii, S., Yang, S., Chong, M., Ungvari, G. S., Si, T., Chung, E. K., Tsang, H., Chan, Y. H., et al. (2004) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2004.02102.x · Cited by 142
Montgomery, J., Winterbottom, E., Jessani, M., Kohegyi, E., Fulmer, J., Seamonds, B., & Josiassen, R. C. (2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n1108 · Cited by 132
Weissman, E. M. (2002) · Schizophrenia Bulletin · doi:10.1093/oxfordjournals.schbul.a006924 · Cited by 127
Improvement In Indices Of Health Status In Outpatients With Schizophrenia Switched To Ziprasidone
Weiden, P. J., Daniel, D. G., Simpson, G. M., & Romano, S. J. (2003) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000095347.32154.08 · Cited by 123
Henderson, D. C., Kunkel, L., Nguyen, D. D., Borba, C. P. C., Daley, T. B., Louie, P. M., Freudenreich, O., Cather, C., Evins, A. E., & GOFF, D. C. (2005) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2005.00612.x · Cited by 113
Antipsychotic medication coprescribing in a large state hospital system
Jaffe, A. B., & Levine, J. (2002) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.783 · Cited by 111
Citrome, L., Jaffe, A. B., Levine, J., Allingham, B., & Robinson, J. (2004) · Psychiatric Services · doi:10.1176/appi.ps.55.9.1006 · Cited by 111
Straker, D., Correll, C. U., Kramer‐Ginsberg, E., Abdulhamid, N., Koshy, F., Rubens, E. O., Saint-Vil, R., Kane, J. M., & Manu, P. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.6.1217 · Cited by 89
Self-citationLong-term combination antipsychotic treatment in VA patients with schizophrenia
Kreyenbuhl, J. A., Valenstein, M. M., McCarthy, J. F., Ganoczy, D. A., & Blow, F. C. (2006) · Schizophrenia Research · doi:10.1016/j.schres.2006.02.023 · Cited by 84
Fourrier, A., Gasquet, I., Allicar, M. P., Bouhassira, M., Lepine, J. P., & Bégaud, B. (2000) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.2000.00108.x · Cited by 77
Testing for diabetes in hospitalised patients prescribed antipsychotic drugs
Taylor, D. M., Young, C., Esop, R., Paton, C., & Walwyn, R. E. A. (2004) · The British Journal of Psychiatry · doi:10.1192/bjp.185.2.152 · Cited by 73
Bovet, P., Faeh, D., Gabriel, A., & Tappy, L. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.11.1236-b · Cited by 49
Aziz, S., & Hsiang, Y.-H. (1983) · Diabetes Care · doi:10.2337/diacare.6.6.529 · Cited by 39
Focus on Antipsychotic polypharmacy: evidence-based prescribing or prescribing-based evidence?
Stahl, S. M. (2004) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145704004146 · Cited by 32
Cited by
Metabolic syndrome in people with schizophrenia: a review
DE HERT, M., SCHREURS, V., VANCAMPFORT, D., & VAN WINKEL, R. (2009) · World Psychiatry · doi:10.1002/j.2051-5545.2009.tb00199.x · Cited by 634
Barnes, T. R., Drake, R., Paton, C., Cooper, S. J., Deakin, B., Ferrier, I. N., Gregory, C. J., Haddad, P. M., Howes, O. D., Jones, I., et al. (2020) · Journal of Psychopharmacology · doi:10.1177/0269881119889296 · Cited by 606
Solmi, M., Murru, A., Pacchiarotti, I., Undurraga, J., Veronese, N., Fornaro, M., Stubbs, B., Monaco, F., Vieta, E., Seeman, M., et al. (2017) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s117321 · Cited by 438
Self-citationCorrell, C. U., Rummel-Kluge, C., Corves, C., Kane, J. M., & Leucht, S. (2009) · Schizophrenia Bulletin · doi:10.1093/schbul/sbn018 · Cited by 397
Self-citationBarnes, T. R., & the Schizophrenia Consensus Group of the British Association for Psychopharmacology (2011) · Journal of Psychopharmacology · doi:10.1177/0269881110391123 · Cited by 356
Metadata
- Authors
- Correll, C. U., Frederickson, A. M., Kane, J. M., & Manu, P.
- Venue
- Schizophrenia Research
- Publisher
- Elsevier BV
- Published
- 2007-01
- Volume
- 89
- Issue
- 1-3
- Pages
- 91-100
- ISSN
- 0920-9964 (ISSN-L)
- OpenAlex
- W2028934174
- Cited by
- 252
- References
- 50
- FWCI
- 6.90
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.